Due to public health concerns related to COVID-19, Larger Than Life Science is going virtual. Join LaunchBio from anywhere in the world to experience our programming for life science entrepreneurs.
Due to public health concerns related to COVID-19, Larger Than Life Science is going virtual. Join LaunchBio from anywhere in the world to experience our programming for life science entrepreneurs. Our webinars will be live-streaming free on Zoom and made available on our website following the program.
Register today and we’ll send you the link to participate.
Advancing Gene Therapy
Tools for Developing Your Candidate Therapy
New gene editing technologies have energized the science of drug discovery and sparked a wave of startups. With the advent of CRISPR/Cas9 systems, a researcher can find an active nuclease on virtually any region of the genome, greatly reducing the time needed to develop novel therapies to treat a wide range of diseases.
But increased choice can lead to problems in building a cell line model yielding the best results. In the first presentation, we’ll address common real-world challenges in cell line engineering and explore methods to avoid the pitfalls.
Naomi Baer, Business Development, Emerging Biotechnology, MilliporeSigma
C.J. Boehler, PhD, Research Technology Specialist- Innovative Life Sciences, MilliporeSigma
Ratish Krishnan, Associate Director, Vaccines & Gene Therapy, MilliporeSigma
(Wednesday) 3:00 pm - 3:45 pm